RxDoctor Payments Data

Brian Vickery

Pediatric Allergy/Immunology · Atlanta, GANPI 1558559906

Payments from drug & device makers

$1,196,951in general payments, 2019–2025

Across 150 payments — averaging $7979.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$414K
  • Novartis$339K
  • AstraZeneca$203K
  • Regeneron$202K
  • Genentech USA, Inc.$34K
  • Aquestive Therapeutics, Inc.$2K
  • plus $3K from 3 others
$421in research payments, 2019–2025

Across 3 payments — averaging $140.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$421

What the payments were for

  • Consulting fees$62,74982%
  • Speaking & faculty fees$5,4607%
  • Travel & lodging$6,3078%
  • Food & beverage$2,4113%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric allergy/immunology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Other pediatric allergy/immunology in Atlanta

Where these figures come from

Is this you, or does something look wrong? →